David Krempa, Chief Business Officer at Eton Pharmaceuticals, sold ETON on Oct 6, 2026

Data as of Oct 16

▼ SELL$229K4,166 shares at $55.07David Krempa Chief Business OfficerETON Eton Pharmaceuticals, Inc.

Watch ETON

Traded: Oct 6, 2026
Disclosed: Oct 6, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

ETONSimilar stocks (XLV — its sector index fund), rebased to ETON's price on the disclosure day

ETON since disclosure

−8.1%

after the sale

Similar stocks (XLV) since disclosure

+5.8%

XLV — its sector index fund

Change in closing price from Oct 6, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on ETON →